(Q44642224)

4 December 2017

title

Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy (English)

1 reference

Cardiology and cardiovascular medicine

4 December 2017

main subject

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(03)00415-0

28 March 2024

author name string

G. Fragasso

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14597947

28 March 2024

P. M. Piatti Md

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14597947

28 March 2024

L. Monti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14597947

28 March 2024

A. Palloshi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14597947

28 March 2024

E. Setola

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14597947

28 March 2024

P. Puccetti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14597947

28 March 2024

G. Calori

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14597947

28 March 2024

G. D. Lopaschuk

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14597947

28 March 2024

A. Margonato

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14597947

28 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S0002870303004150?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(03)00415-0

https://api.elsevier.com/content/article/PII:S0002870303004150?httpAccept=text/plain

28 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(03)00415-0

28 March 2024

published in

American Heart Journal

1 reference

4 December 2017

volume

146

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

E18

1 reference

Effects of trimetazidine on pHi regulation in the rat isolated ventricular myocyte

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Internal pH, Na+, and Ca2+ regulation by trimetazidine during cardiac cell acidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Effect of trimetazidine on membrane damage induced by oxygen free radicals in human red cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Myocardial substrate metabolism: implications for diabetic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Metabolic management of ischaemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Effect of myocardial ischaemia and antilipolytic agents on lipolysis and fatty acid metabolism in the in situ dog heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Beta adrenergic blockade. Hemodynamics and myocardial energy metabolism in patients with ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

The relative contribution of glucose and fatty acids to ATP production in hearts reperfused following ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

THE PATHOGENESIS OF CARDIAC CACHEXIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Metabolic responses to graded exercise in chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Dichloroacetate as metabolic therapy for myocardial ischemia and failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Effects of dichloroacetate on the metabolism of glucose, pyruvate, acetate, 3-hydroxybutyrate and palmitate in rat diaphragm and heart muscle in vitro and on extraction of glucose, lactate, pyruvate and free fatty acids by dog heart in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Glucose metabolism in the ischemic heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Effects of trimetazidine on ischemic contracture in isolated perfused rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Improvement of long-term preservation of isolated arrested rat heart: beneficial effect of the antiischemic agent trimetazidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Effects of trimetazidine on metabolic and functional recovery of postischemic rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Is the failing heart energy depleted?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Trimetazidine increases phospholipid turnover in ventricular myocyte

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900415-0

Glucose, insulin, potassium in acute myocardial infarction

7 January 2021

13

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(03)00415-0

28 March 2024

Identifiers

1 reference

4 December 2017

1 reference